| Product Code: ETC7544720 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India HER2 Positive Breast Cancer Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India HER2 Positive Breast Cancer Treatment Market - Industry Life Cycle |
3.4 India HER2 Positive Breast Cancer Treatment Market - Porter's Five Forces |
3.5 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India HER2 Positive Breast Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2 positive breast cancer in India |
4.2.2 Rising awareness about advanced treatment options for HER2 positive breast cancer |
4.2.3 Technological advancements in HER2 positive breast cancer treatment |
4.3 Market Restraints |
4.3.1 High cost of HER2 targeted therapies |
4.3.2 Limited access to advanced treatment facilities in certain regions of India |
4.3.3 Stringent regulatory requirements for approval of new HER2 positive breast cancer treatments |
5 India HER2 Positive Breast Cancer Treatment Market Trends |
6 India HER2 Positive Breast Cancer Treatment Market, By Types |
6.1 India HER2 Positive Breast Cancer Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.4 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.6 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India HER2 Positive Breast Cancer Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 India HER2 Positive Breast Cancer Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India HER2 Positive Breast Cancer Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 India HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India HER2 Positive Breast Cancer Treatment Market Import-Export Trade Statistics |
7.1 India HER2 Positive Breast Cancer Treatment Market Export to Major Countries |
7.2 India HER2 Positive Breast Cancer Treatment Market Imports from Major Countries |
8 India HER2 Positive Breast Cancer Treatment Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of HER2 targeted therapies in different regions of India |
8.3 Number of clinical trials conducted for new HER2 positive breast cancer treatments |
8.4 Rate of early detection of HER2 positive breast cancer |
8.5 Patient satisfaction with treatment outcomes and quality of life |
9 India HER2 Positive Breast Cancer Treatment Market - Opportunity Assessment |
9.1 India HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 India HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India HER2 Positive Breast Cancer Treatment Market - Competitive Landscape |
10.1 India HER2 Positive Breast Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 India HER2 Positive Breast Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here